Definium Therapeutics, Inc. (DFTX) vs Dianthus Therapeutics, Inc. (DNTH)
A side-by-side comparison of Definium Therapeutics, Inc. and Dianthus Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DFTX
Definium Therapeutics, Inc.
$35.27HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
DNTH
Dianthus Therapeutics, Inc.
$85.92HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Total return — DFTX vs DNTH
growth of $100 · dividends reinvested · last 8yDFTX +1739.1% (+43.9%/yr)DNTH -62.1% (-11.4%/yr)DFTX compounded faster over this window
Log scale — wide-divergence pair
DFTX DNTH
DFTX vs DNTH: by the numbers
- •DNTH is the larger company ($4.81B vs $4.68B market cap).
- •Both run net losses; DFTX's is the smaller (0.00% vs -1570.85% net margin).
Metrics side by side
Valuation
| Metric | DFTX | DNTH |
|---|---|---|
| P/S ratio | N/A | 2524.15 |
| P/B ratio | 5.10 | 4.10 |
Profitability
| Metric | DFTX | DNTH |
|---|---|---|
| Gross margin | 0.00% | 96.01% |
| Operating margin | 0.00% | -8739.34% |
| Net margin | 0.00% | -1570.85% |
| ROE | -38.51% | -2.55% |
| ROIC | -23.81% | -18.48% |
Growth (annualized)
| Metric | DFTX | DNTH |
|---|---|---|
| Total return CAGR (5Y) | 1.43% | -5.50% |
Frequently asked
- How have DFTX and DNTH total returns compared?
- Over the past 5 years, DFTX delivered 1.43% and DNTH delivered -5.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.